Citations

Showing 10 of 108162 citations.

Impact of flow pattern, body mass index, and age on intraprocedural fluoroscopic time and radiation dose during sacroiliac joint injections
Tiegs‐Heiden, Christin A. , Murthy, Naveen S. , Geske, Jennifer R. , Verdoorn, Jared T. , McKenzie, Gavin , Diehn, Felix E. , Lehman, Vance T. , Liebo, Greta B. , Verdoorn, Jared T , McKenzie, Gavin A , Tiegs-Heiden, Christin A , Geske, Jennifer , Carr, Carrie M.

Mayo Clinic

The Neuroradiology Journal | March 9, 2021 | Volume: 34 | Issue: 5 | Pages: 428-434

10.1177/1971400921998966 | PMID 33685248 Get It

Purpose Understanding all factors that may impact radiation dose and procedural time is crucial to safe and efficient image-guided interventions, such as fluoroscopically guided sacroiliac (SI) joint injections. The purpose of this study was to evaluate the effect of flow pattern (intra- vs. periarticular), patient age, and body mass index (BMI) on radiation dose and fluoroscopy time. Methods A total of 134 SI joint injections were reviewed. Injectate flow pattern, age, and BMI were analyzed in respect to fluoroscopy time (minutes), radiation dose (kerma area product (KAP); µGy m 2 ), and estimated skin dose (mGy). Results BMI did not affect fluoroscopy time, but increased BMI resulted in significantly higher skin and fluoroscopy doses ( p < 0.001). There was no association between fluoroscopy time and flow pattern. Higher skin dose was associated with intraarticular flow ( p = 0.0086), and higher KAP was associated with periarticular flow ( p = 0.0128). However, the odds ratios were close to 1. There was no significant difference between fluoroscopy time or dose based on patient age. Conclusion Increased BMI had the largest impact on procedural radiation dose and skin dose. Flow pattern also showed a statistically significant association with radiation dose and skin dose, but the clinical difference was small. Proceduralists should be aware that BMI has the greatest impact on fluoroscopy dose and skin dose during SI joint injections compared to other factors.
A systematic review of adherence to physical activity interventions in individuals with type 2 diabetes
MacDonald, Christopher , Ried‐Larsen, Mathias , Soleimani, Jalal , Alsawas, Mouaz , Ismail, Abdalla, Serafim, Laura Piccolo, Yang, Ting , Prokop, Larry, Joyner, Michael J. , Barwise, Amelia , MacDonald, Christopher S , Joyner, Michael, Murad, Mohammad Hassan, Barwise, Amelia K , Joyner, Michael J , Alsawas, Mouaz , Lieberman, Daniel E. , Murad, M. Hassan

Mayo Clinic

Diabetes/Metabolism Research and Reviews | March 9, 2021 | Volume: 37 | Issue: 8 | Pages: No page available

10.1002/dmrr.3444 | PMID 33769660 Get It

Abstract Lifestyle interventions are pivotal for successful management of type 2 diabetes (T2D), however, the proportion of people with T2D adhering to physical activity advice has not been thoroughly studied. The purpose of this systematic review was to summarise the evidence on adherence to exercise or physical activity components in lifestyle interventions in those with T2D. We searched MEDLINE EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Scopus on 12 November 2019. Eligible studies enrolled adults with T2D and reported the proportion of adherence to lifestyle interventions as a primary or secondary outcome. We included 11 studies (nine randomised controlled trials (RCTs) enrolling 1717 patients and two nonrandomised studies enrolling 62 patients). Only one of the studies had low risk of bias. The proportion of participants adhering to physical activity varied from 32% to 100% with a median of 58%. Adherence was higher in interventions using supervised training and lowest in interventions using remote coaching and the adherence rate in observational studies was higher compared to RCTs (92% vs. 55%; p < 0.01). Study duration, risk of bias, or participants' sex, were not associated with adherence to physical activity. The proportion of those with T2D adhering to physical activity interventions for T2D varies widely and most of the included studies had a high risk of bias. These findings have important implications for planning and power analysis of future trials and when counselling patients about lifestyle interventions including physical activity or exercise components.
Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction
Wolsk, Emil , Komtebedde, Jan , Kitzman, Dalane W. , Cleland, John G.F. , Hassager, Christian , Gustafsson, Finn , Hassager, Christian , Gustafsson, Finn , Kaye, David M. , Shah, Sanjiv J , Borlaug, Barry A. , Burkhoff, Daniel , Hasenfuß, Gerd , Møller, Jacob Eifer , Cleland, John G F

Mayo Clinic

European Journal of Heart Failure | March 9, 2021 | Volume: 23 | Issue: 5 | Pages: 754-764

10.1002/ejhf.2146 | PMID 33686716 Get It

Abstract Aims A hallmark of heart failure with preserved ejection fraction (HFpEF) is impaired exercise capacity of varying severity. The main determinant of exercise capacity is cardiac output (CO), however little information is available about the relation between the constituents of CO – heart rate and stroke volume – and exercise capacity in HFpEF. We sought to determine if a heterogeneity in heart rate and stroke volume response to exercise exists in patients with HFpEF and describe possible clinical phenotypes associated with differences in these responses. Methods and results Data from two prospective trials of HFpEF ( n = 108) and a study of healthy participants ( n = 42) with invasive haemodynamic measurements during exercise were utilized. Differences in central haemodynamic responses were analysed with regression models. Chronotropic incompetence was present in 39–56% of patients with HFpEF and 3–56% of healthy participants depending on the definition used, but some ( n = 47, 44%) had an increase in heart rate similar to that of healthy controls. Patients with HFpEF had a smaller increase in their stroke volume index (SVI) (HFpEF: +4 ± 10 mL/m 2 , healthy participants: +24 ± 12 mL/m 2 , P < 0.0001), indeed, SVI fell in 28% of patients at peak exercise. Higher body mass index and lower SVI at rest were associated with smaller increases in heart rate during exercise, whereas higher resting heart rate, and angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker use were associated with a greater increase in SVI in patients with HFpEF. Conclusion The haemodynamic response to exercise was very heterogeneous among patients with HFpEF, with chronotropic incompetence observed in up to 56%, and 28% had impaired increase in SVI. This suggests that haemodynamic exercise testing may be useful to identify which HFpEF patients may benefit from interventions targeting stroke volume and chronotropic response.
Differences in Temporal Volume between Males and Females and the Influence of Age and BMI: A Cross-Sectional CT-Imaging Study
Nikolis, Andreas , Frank, Konstantin , Guryanov, R. A. , Gombolevskiy, Victor А. , Makhmud, Kamal, Green, Jeremy Blair, Морозов, С. П. , Chernina, Valeria Y. , Gotkin, Robert H. , Cotofana, Sebastian

Mayo Clinic

Facial Plastic Surgery | March 9, 2021 | Volume: 37 | Issue: 05 | Pages: 632-638

10.1055/s-0041-1725201 | PMID 33684952 Get It

Abstract Background The temple has been identified as one of the most compelling facial regions in which to seek aesthetic improvement—both locally and in the entire face—when injecting soft tissue fillers. Objective The objective of this study is to identify influences of age, gender, and body mass index (BMI) on temporal parameters to better understand clinical observations and to identify optimal treatment strategies for treating temporal hollowing. Methods The sample consisted of 28 male and 30 female individuals with a median age of 53 (34) years and a median BMI of 27.00 (6.94) kg/m2. The surface area of temporal skin, the surface area of temporal bones, and the temporal soft tissue volume were measured utilizing postprocessed computed tomography (CT) images via the Hausdorff minimal distance algorithm. Differences between the investigated participants related to age, BMI, and gender were calculated. Results Median skin surface area was greater in males compared with females 5,100.5 (708) mm2 versus 4,208.5 (893) mm2 (p < 0.001) as was the median bone surface area 5,329 (690) mm2 versus 4,477 (888) mm2 (p < 0.001). Males had on average 11.04 mL greater temporal soft tissue volume compared with age and BMI-matched females with p < 0.001. Comparing the volume between premenopausal versus postmenopausal females, the median temporal soft tissue volume was 46.63 mL (11.94) versus 40.32 mL (5.69) (p = 0.014). Conclusion The results of this cross-sectional CT imaging study confirmed previous clinical and anatomical observations and added numerical evidence to those observations for a better clinical integration of the data.
Novel Focal Therapeutic Hypothermia Device for Treatment of Acute Neurologic Injury: Large Animal Safety and Efficacy Trial
Perry, Avital , Graffeo, Christopher S. , Ding, Yong Hong, Jakaitis, Daniel R. , Lu, Aiming , Rodgers, Seth, Kreck, Thomas, Hoofer, Kelly, Gorny, Krzysztof R. , Kadirvel, Ramanathan , Kallmes, David F. , Carlstrom, Lucas P. , Dai, Daying , Ding, Yong H, Ding, Yonghong

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 9, 2021 | Volume: 83 | Issue: 02 | Pages: 203-209

10.1055/s-0040-1721818 | PMID 35433184 Get It

Abstract Objective Therapeutic hypothermia is a potentially powerful and controversial clinical tool for neuroprotection following acute neurologic pathology, particularly vascular injury. Indeed, therapeutic hypothermia remains a standard of care for postcardiac arrest ischemia and acute neonatal hypoxic-ischemic encephalopathy, improving both survival and outcomes. Although therapeutic hypothermia remains promising for cellular and systems-based neuronal protection in other neurologic injury states, the systemic side effects have limited clinical utility, confounded analysis of potential neurologic benefits, and precluded the completion of meaningful clinical trials. Methods To address such limitations, we developed and tested a novel, minimally invasive, neurocritical care device that employs continuous circulation of cold saline through the pharyngeal region to deliver focal cerebrovascular cooling. We conducted a preclinical safety and efficacy trial in six adult porcine animals to assess the validity and functionality of the NeuroSave device, and assess cooling potential following middle cerebral artery occlusion (n = 2). Results NeuroSave consistently lowered brain parenchymal temperature by a median of 9°C relative to core temperature within 60 minutes of initiation, including in ischemic cerebral parenchyma. The core body temperature experienced a maximal reduction of 2°C, or 5% of body temperature, with no associated adverse effects identified. Conclusion The present study uses a large animal preclinical model to demonstrate the safety and efficacy of a novel, noninvasive device for the induction of robust and systemically safe hypothermia within the brain.
Electronic Health Record Acceptance by Physicians: A Single Hospital Experience in Daily Practice
Pavlović, Andrija , Rajović, Nina , Stojanovic, Jasmina Pavlovic, Akinyombo, Debora , Ugljesic, Milica, Pavlica, Marina , Pavlović, Vedrana , Randjelovic, Simona, Spaić, Dragan , Mašić, Srdjan , Milić, Nataša , Milic, N , Rajovic, Nina , Masic, Srdjan , Ugljesic, M, Stanisavljević, Dejana

Mayo Clinic

BioMedInformatics | March 8, 2021 | Volume: 1 | Issue: 1 | Pages: 6-17

10.3390/biomedinformatics1010002 Get It

Introduction: Potential benefits of implementing an electronic health record (EHR) to increase the efficiency of health services and improve the quality of health care are often obstructed by the unwillingness of the users themselves to accept and use the available systems. Aim: The aim of this study was to identify factors that influence the acceptance of the use of an EHR by physicians in the daily practice of hospital health care. Material and Methods: The cross-sectional study was conducted among physicians in the General Hospital Pancevo, Serbia. An anonymous questionnaire, developed according to the technology acceptance model (TAM), was used for the assessment of EHR acceptance. The response rate was 91%. Internal consistency was assessed by Cronbach’s alpha coefficient. A logistic regression analysis was used to identify the factors influencing the acceptance of the use of EHR. Results: The study population included 156 physicians. The mean age was 46.4 ± 10.4 years, 58.8% participants were female. Half of the respondents (50.1%) supported the use of EHR in comparison to paper patient records. In multivariate logistic regression modeling of social and technical factors, ease of use, usefulness, and attitudes towards use of EHR as determinants of the EHR acceptance, the following predictors were identified: use of a computer outside of the office for reading daily newspapers (p = 0.005), EHR providing a greater amount of valuable information (p = 0.007), improvement in the productivity by EHR use (p < 0.001), and a statement that using EHR is a good idea (p = 0.014). Overall the percentage of correct classifications in the model was 83.9%. Conclusion: In this research, determinants of the EHR acceptance were assessed in accordance with the TAM, providing an overall good model fit. Future research should attempt to add other constructs to the TAM in order to fully identify all determinants of physician acceptance of EHR in the complex environment of different health systems.
Comparison of 1 vs 2 Brain Death Examinations on Time to Death Pronouncement and Organ Donation
Varelas, Panayiotis N. , Rehman, Mohammed, Mehta, Chandan, Louchart, Lisa, Schultz, Lonni, Brady, Paul, Kananeh, Mohammed , Wijdicks, Eelco F. M. , Kananeh, Mohammed F, Wijdicks, Eelco Fm , Brady, Paul

Mayo Clinic

Neurology | March 8, 2021 | Volume: 96 | Issue: 10 | Pages: No page available

10.1212/wnl.0000000000011554 | PMID 33514644 Get It

Using nursing notes to improve clinical outcome prediction in intensive care patients: A retrospective cohort study
Huang, Kexin , Gray, Tamryn F. , Tulsky, James A. , Romero-Brufau, Santiago, Romero‐Brufau, Santiago , Lindvall, Charlotta

Mayo Clinic

Journal of the American Medical Informatics Association | March 8, 2021 | Volume: 28 | Issue: 8 | Pages: 1660-1666

10.1093/jamia/ocab051 | PMID 33880557 Get It

Abstract Objective Electronic health record documentation by intensive care unit (ICU) clinicians may predict patient outcomes. However, it is unclear whether physician and nursing notes differ in their ability to predict short-term ICU prognosis. We aimed to investigate and compare the ability of physician and nursing notes, written in the first 48 hours of admission, to predict ICU length of stay and mortality using 3 analytical methods. Materials and Methods This was a retrospective cohort study with split sampling for model training and testing. We included patients ≥18 years of age admitted to the ICU at Beth Israel Deaconess Medical Center in Boston, Massachusetts, from 2008 to 2012. Physician or nursing notes generated within the first 48 hours of admission were used with standard machine learning methods to predict outcomes. Results For the primary outcome of composite score of ICU length of stay ≥7 days or in-hospital mortality, the gradient boosting model had better performance than the logistic regression and random forest models. Nursing and physician notes achieved area under the curves (AUCs) of 0.826 and 0.796, respectively, with even better predictive power when combined (AUC, 0.839). Discussion Models using only nursing notes more accurately predicted short-term prognosis than did models using only physician notes, but in combination, the models achieved the greatest accuracy in prediction. Conclusions Our findings demonstrate that statistical models derived from text analysis in the first 48 hours of ICU admission can predict patient outcomes. Physicians’ and nurses’ notes are both uniquely important in mortality prediction and combining these notes can produce a better predictive model.
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers in a surgical environment
Ruyter, Martin L. De, Parkulo, Mark A. , Hedges, Mary S. , Brinker, Todd M., Márquez, Cortés, Rubel, Nicholas , Simon, FM, Logvinov, Ilana I. , Li, Z , Bosch, Wendelyn , Hedges, Mary S , Logvinov, Ilana , Harris, Dana M.

Mayo Clinic

British Journal of Surgery | March 8, 2021 | Volume: 108 | Issue: 8 | Pages: e258-e259

10.1093/bjs/znab109 | PMID 34151351 Get It

Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy
Jing, Ying , Zhang, Yongchang , Li, Kunyan , Chen, Xue , Heng, Jianfu, Gao, Qian , Ye, Youqiong , Zhang, Zhao , Liu, Yaoming , Lou, Yanyan , Diao, Lixia , Han, Leng , Ye, Youqiong , Zhang, Zhao , Lin, Steven H , Han, Leng , Wang, Jing , Lin, Steven H. , Liu, Hong , Chen, Xiang , Mills, Gordon B.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | March 8, 2021 | Volume: 113 | Issue: 10 | Pages: 1396-1404

10.1093/jnci/djab035 | PMID 33705549 Get It

Abstract Background Accumulated evidence supports the existence of sex-associated differences in immune systems. Understanding the role of sex in immune-related adverse events (irAEs) is important for management of irAE in patients receiving immunotherapy. Methods We performed meta-analysis on published clinical study data and multivariable logistic regression on pharmacovigilance data and applied a propensity algorithm to The Cancer Genome Atlas omics data. We further validated our observations in 2 independent in-house cohorts of 179 and 767 cancer patients treated with immune checkpoint inhibitors. Results A meta-analysis using 13 clinical studies that reported on 1096 female patients (36.8%, 95% confidence interval [CI] = 35.0% to 38.5%) and 1886 male patients (63.2%, 95% CI = 61.5% to 65.0%) demonstrated no statistically significant irAE risk difference between the sexes (odds ratio [OR] = 1.19, 95% CI = 0.91 to 1.54, 2-sided P = .21). Multivariable logistic regression analysis of 12 225 patients from the Food and drug administration Adverse Event Reporting System (FAERS) and 10 979 patients from VigiBase showed no statistically significant difference in irAEs by sex. A propensity score algorithm used on multi-omics data for 6019 patients from The Cancer Genome Atlas found no statistically significant difference by sex for irAE-related factors or pathways. The retrospective analysis of 2 in-house patient cohorts validated these results (OR = 1.55, 95% CI = 0.98 to 2.47, false discovery rate = 0.13, for cohort 1; OR = 1.16, 95% CI = 0.86 to 1.57, false discovery rate = 0.39, for cohort 2). Conclusions We observed minimal sex-associated differences in irAEs among cancer patients who received immune checkpoint inhibitor therapy. It may be unnecessary to consider sex effects for irAE management in clinical practice.